Incidence of adverse events after high doses of onabotulinumtoxina for multiple indications

Urology

Volumn 84, Issue 5, 2014, Pages 1044-1048

  Nuanthaisong, Umaphorn ^a,b   Abraham, Nitya ^a   Goldman, Howard B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DETRUSOR DYSSYNERGIA; DRUG MEGADOSE; FEMALE; HUMAN; LEG PAIN; LIMB WEAKNESS; MALE; MIDDLE AGED; OVERACTIVE BLADDER; RETROSPECTIVE STUDY; SPASTICITY; TREATMENT INDICATION; URINE INCONTINENCE; COMPLICATION; INCIDENCE; LIMB; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PATHOLOGY; TIME; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; EXTREMITIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 84908331292     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.07.046     Document Type: Article

References (18)

1. A. Partikian, and W.G. Mitchell Iatrogenic botulism in a child with spastic quadriparesis J Child Neurol 22 2007 1235 1237
2. Irvine, CA Allergan: Botox: OnabotulinumtoxinA Full Prescribing Information 2013
3. D.Z. de Beyl, CL, and A. Yakovleff A multicenter, double-blind, placebo-controlled trial to evaluate dosing, safety, and efficacy of intramuscular botulinum toxin type A for the management of upper limb spasticity poststroke Eur J Neurol 7 Suppl 3 2000 23
4. M.K. Childers, A. Brashear, and P. Jozefczyk Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke Arch Phys Med Rehabil 85 2004 1063 1069
5. D.S. Chertow, E.T. Tan, and S.E. Maslanka Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation JAMA 296 2006 2476 2479
6. A. Coban, Z. Matur, H.A. Hanagasi, and Y. Parman Iatrogenic botulism after botulinum toxin type A injections Clin Neuropharmacol 33 2010 158 160
7. M. Ghasemi, R. Norouzi, M. Salari, and B. Asadi Iatrogenic botulism after the therapeutic use of botulinum toxin-A: a case report and review of the literature Clin Neuropharmacol 35 2012 254 257
8. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=312.32, Accessed on July 21, 2014.
9. A. Brashear, M.F. Gordon, and E. Elovic Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 2002 395 400
10. M. Kennelly, R. Dmochowski, and K. Ethans Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis Urology 81 2013 491 497
11. F. Mancini, G. Sandrini, and A. Moglia A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot Neurol Sci 26 2005 26 31
12. A.B. Scott, and D. Suzuki Systemic toxicity of botulinum toxin by intramuscular injection in the monkey Mov Disord 3 1988 333 335
13. Irvine, CA Allergan, Allergan Annual Report 2012
14. N.I. Mejia, K.D. Vuong, and J. Jankovic Long-term botulinum toxin efficacy, safety, and immunogenicity Mov Disord 20 2005 592 597
15. J. Jankovic, K.D. Vuong, and J. Ahsan Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia Neurology 60 2003 1186 1188
16. M. Naumann, A. Carruthers, and J. Carruthers Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications Mov Disord 25 2010 2211 2218
17. P.A. Hanna, and J. Jankovic Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response Neurology 50 1998 1624 1629
18. C. Dowson, M.S. Khan, P. Dasgupta, and A. Sahai Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity Nat Rev Urol 7 2010 661 667